Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily LLY Bull 2X Shares

25.89
-0.3513-1.34%
Post-market: 26.040.1513+0.58%19:58 EDT
Volume:51.75K
Turnover:1.36M
Market Cap:14.89M
PE:- -
High:26.63
Open:26.44
Low:25.85
Close:26.24
52wk High:35.13
52wk Low:14.58
Shares:575.00K
Float Shares:575.00K
Volume Ratio:0.75
T/O Rate:9.00%
Dividend:3.17
Dividend Rate:12.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 24

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
Aug 24

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
Aug 24

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Aug 24

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Aug 24

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?

Simply Wall St.
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20

World's Largest Companies by Market Cap (July 2026): Nvidia Leads, AI Theme Intact but Chip Stocks Face Valuation Adjustments

TradingKey
·
Aug 20

Eli Lilly on Track for Record High Close

Dow Jones
·
Aug 20

Eli Lilly Advances Oral Pipeline With New LY4065967 Formulation Study

TIPRANKS
·
Aug 20